- Home
- HKIT vs PEPG Comparison
HKIT vs PEPG Comparison
Compare HKIT & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- PEPG
- Stock Information
- Founded
- HKIT 1996
- PEPG 2018
- Country
- HKIT China
- PEPG United States
- Employees
- HKIT N/A
- PEPG N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- PEPG Health Care
- Exchange
- HKIT Nasdaq
- PEPG Nasdaq
- Market Cap
- HKIT 39.8M
- PEPG 43.2M
- IPO Year
- HKIT 2023
- PEPG 2022
- Fundamental
- Price
- HKIT $1.55
- PEPG $1.07
- Analyst Decision
- HKIT
- PEPG Buy
- Analyst Count
- HKIT 0
- PEPG 3
- Target Price
- HKIT N/A
- PEPG $7.67
- AVG Volume (30 Days)
- HKIT 19.7K
- PEPG 183.8K
- Earning Date
- HKIT 04-29-2025
- PEPG 08-07-2025
- Dividend Yield
- HKIT N/A
- PEPG N/A
- EPS Growth
- HKIT N/A
- PEPG N/A
- EPS
- HKIT N/A
- PEPG N/A
- Revenue
- HKIT $2,904,950.00
- PEPG N/A
- Revenue This Year
- HKIT N/A
- PEPG N/A
- Revenue Next Year
- HKIT N/A
- PEPG N/A
- P/E Ratio
- HKIT N/A
- PEPG N/A
- Revenue Growth
- HKIT N/A
- PEPG N/A
- 52 Week Low
- HKIT $1.15
- PEPG $0.88
- 52 Week High
- HKIT $1.86
- PEPG $10.15
- Technical
- Relative Strength Index (RSI)
- HKIT 62.60
- PEPG 31.84
- Support Level
- HKIT $1.38
- PEPG $1.37
- Resistance Level
- HKIT $1.62
- PEPG $1.46
- Average True Range (ATR)
- HKIT 0.07
- PEPG 0.11
- MACD
- HKIT 0.02
- PEPG -0.03
- Stochastic Oscillator
- HKIT 65.52
- PEPG 2.44
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.